GB0206091D0 - New medical use - Google Patents

New medical use

Info

Publication number
GB0206091D0
GB0206091D0 GBGB0206091.1A GB0206091A GB0206091D0 GB 0206091 D0 GB0206091 D0 GB 0206091D0 GB 0206091 A GB0206091 A GB 0206091A GB 0206091 D0 GB0206091 D0 GB 0206091D0
Authority
GB
United Kingdom
Prior art keywords
medical use
new medical
new
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0206091.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0206091.1A priority Critical patent/GB0206091D0/en
Publication of GB0206091D0 publication Critical patent/GB0206091D0/en
Priority to AU2003209489A priority patent/AU2003209489A1/en
Priority to PCT/GB2003/001025 priority patent/WO2003077909A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0206091.1A 2002-03-15 2002-03-15 New medical use Ceased GB0206091D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0206091.1A GB0206091D0 (en) 2002-03-15 2002-03-15 New medical use
AU2003209489A AU2003209489A1 (en) 2002-03-15 2003-03-12 Medical use of captopril for the treatment and prophylaxis of cancer
PCT/GB2003/001025 WO2003077909A1 (en) 2002-03-15 2003-03-12 Medical use of captopril for the treatment and prophylaxis of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0206091.1A GB0206091D0 (en) 2002-03-15 2002-03-15 New medical use

Publications (1)

Publication Number Publication Date
GB0206091D0 true GB0206091D0 (en) 2002-04-24

Family

ID=9933009

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0206091.1A Ceased GB0206091D0 (en) 2002-03-15 2002-03-15 New medical use

Country Status (3)

Country Link
AU (1) AU2003209489A1 (en)
GB (1) GB0206091D0 (en)
WO (1) WO2003077909A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009048540A1 (en) * 2007-10-05 2009-04-16 U.S. Department Of Veterans Affairs Office Of General Counsel - Psg Iv (024) Method and composition for treating heart failure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9700933D0 (en) * 1997-01-17 1997-03-05 Cancer Res Campaign Tech Process for developing or identifying drugs for the treatment or prevention of cancer or osteoporosis

Also Published As

Publication number Publication date
AU2003209489A1 (en) 2003-09-29
WO2003077909A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
PL372902A1 (en) New use
GB0307918D0 (en) Therapeutic use
GB0206048D0 (en) Use
GB0227666D0 (en) Use
AU2003259457A8 (en) Auto-destructible syringe
GB0217056D0 (en) Use
GB0306604D0 (en) Second medical use
AU2003255372A8 (en) Medical device
GB0213878D0 (en) Use
GB0219660D0 (en) Therapeutic use
GB0203332D0 (en) Medical device
GB0206838D0 (en) Use
GB0230343D0 (en) Use
GB0206091D0 (en) New medical use
EP1625830A4 (en) Medical menipulator
GB0229442D0 (en) Use
GB0220064D0 (en) New therapeutic use
GB0216128D0 (en) New therapeutic use
GB0229744D0 (en) New therapeutic use
GB0222478D0 (en) New therapeutic use
GB0226865D0 (en) Therapeutic use
GB0226850D0 (en) Therapeutic use
GB0224787D0 (en) Therapeutic use
GB0223118D0 (en) Therapeutic use
GB0311457D0 (en) New therapeutic use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)